Additional file 3 of A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)

Authors :: Yoshida, Soichiro
Takahara, Taro
Arita, Yuki
Ito, Masaya
Hayakawa, Sara
Oguchi, Tomohiko
Komai, Yoshinobu
Numao, Noboru
Yuasa, Takeshi
Inoue, Masaharu
Ushijima, Hiroki
Kudo, Shigehiro
Shimano, Yasumasa
Nakamura, Yuki
Uchida, Yusuke
Uehara, Sho
Tanaka, Hajime
Yaegashi, Hiroshi
Izumi, Kouji
Yokoyama, Minato
Matsuoka, Yoh
Yoshioka, Yasuo
Konishi, Koji
Nakanishi, Katsuyuki
Nagahara, Akira
Hirakawa, Akihiro
Koike, Ryuji
Koga, Fumitaka
Nishimura, Kazuo
Mizokami, Atsushi
Yonese, Junji
Kageyama, Yukio
Yoshimura, Ryoichi
Fujii, Yasuhisa
Publication Year :: 2023
Publisher :: figshare, 2023.
Abstract: Additional file 3: The consent form given to participants.

Full Text Access

Tools